Menu

ImmunityBio, Inc. IBRX

Full chart Compare
Set alert

Price alert · IBRX

All alert types
6.07 USD -0.60 (-9.00%)

At closeNov 12, 2026, 7:59 PM EST

6.14 +0.07 +1.09%

After hours · Nov 12, 7:59 PM ET

6.00 Day range 6.50
1.98 52-week range 11.55
YTD
+206.57%
1 year
+194.66%

Discussion (3506)

Sign in to join the discussion

frank fager IBRX 6 months ago #1312

Daredevil go fuck yourself your posts are lies. ImmunityBio has revenue

frank fager IBRX 6 months ago #1314

It's way more fun when it goes up.

Sales will explode and earnings will happen and more approvals will happen. When those things happen the stock explodes higher.

frank fager IBRX 6 months ago #1315

Need to relax and remember the science and the huge potential. Shorts are not an issue over time so ignore the short term focus on the 2-5 years potential

frank fager IBRX 6 months ago #1316

Maybe FDA is dragging feet so Medicare and Medicaid and other insurance carriers won't be required to pay

frank fager IBRX 6 months ago #1317

Lance

I agree.... Anktiva will have more uses then Keytruda and it will happen fast and it works when Keytruda is failing.

frank fager IBRX 6 months ago #1318

The clinical data say Anktiva works for papillary bladder cancer and prevents bladder removal.

It will be approved and should have been before. FDA was protecting 80% of the bladder cancer market for hello Keytruda and Merck.

frank fager IBRX 6 months ago #1319

Paul Silberberg

love your posts!!!!

The FDA has no credibility. They have approved so many drugs with horrific side effects. They gave mRNA jabs for Covid emergency use authorization and as many many side effects surfaced they never rescinded it and still have not.